µÚËľüÒ½´óѧһ¾Å¾Å¶þÄê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧÊÔÌâ ѧ¿Æ×¨Òµ£º S{. G=O
gxf{/EjH
´«È¾²¡Ñ§ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ r)Dln5F
@Fs2J_v
Ò». Ãû´Ê½âÊÍ(ÿÌâ4·Ö,¹²32·Ö) NKJ+DD:'
Wd78 bu|
1. ICAM-1 y?4%
eD
8n`O{8:fi
2. interleukin 12(IL-12) ,rZp(moj
)~CnDk}^R
3. tumor infiltrating lymphocyte
!`$xN~_
XI"8d.VR
4. TCR/CD3 complex ,y%4QvG7a
\ =(r6X
5. hematopoietin receptor family
AIK99
8kA2.pIk
6. individual idiotype(IdI) {@tqeu%IM
sH_5.+,`
7. integrin Rx,Qw> #
:<w2j6V
8. colony-stimulatory factor (CSF) vC1D}=Fp
0! 6n
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© %4
0uw3
0[SJ7k19
1. ÃâÒßÇòµ°°×ÖØÁ´µÄ»ùÒòÈçºÎ½øÐÐÀà±ðת»»(class switching )? W7 iml|WV0
\f6@B:?y
2. ¼òÊöɱÉËÐÔTϸ°û(Tc)ɱÉ˲¡¶¾¸ÐȾ°Ðϸ°ûµÄ»úÀí¡£ hnf7Q l}
C % d
3. ÉúÎïÓ¦´ðµ÷½Ú¼Á( biological response modifier,BRM)Ö÷ÒªÓÐÄļ¸Àà?¼òÒª½éÉÜÔÚ´«È¾ÐÔ¼²²¡·ÀÖÎÖеÄ×÷Óᣠ'1u!@=.\G
CRKuN
4. ¼òÊö¿¹ÔÌá³Êϸ°û(APC)Ó븨ÖúÐÔTϸ°û(Th)Ï໥×÷ÓõĹØÏµ¡£ [@RJ2q$
=!pfgE
Èý. ÎÊ´ðÌâ(ÿÌâ18·Ö,¹²36·Ö) gs?=yNL
H)u<$y!8
1. ÊÔÊö¸ÉÈÅËØµÄ·ÖÀ༰ÆäÉúÎïѧ×÷ÓÃÌØµã¡£Ö÷Òª¿ÉÒÔÖÎÁÆÄÄЩ´«È¾ÐÔ¼²²¡?¼òÊö¸ÉÈÅËØ¼ì²âµÄ·½·¨ºÍÔÀí¡£ h0v4!`PQ-
V_.n G;
2. ºÎΪ»ùÒò¹¤³Ì¿¹Ìå?Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? µÚËľüÒ½´óѧһ¾Å¾ÅÈýÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: ´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: ÃâÒßѧ Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© 1. CD4 2. T cell receptor(TCR) +2WvGRC
wy)I6`v
3. immunoglobulin superfamily (IgSF) =^L?Sgg
`EjPy>kM
4. selectin 'c")]{
`_*NFv1_
5. anti-idiotypic antibody (¦ÁId) v\;hI5WY
`VB]4i}u
6. major histocompatibility complex(MHC) )X
dpzWod
R,'`
A.Kk
7. immunotolerance Ie14`'
\4B2%H
8. biological reponse modifier(BRM) Z\@m_/g
FN)vFQ#J
9. immune reponse gene (Ir gene) [l9iWs'M
/6$8djw
10. reshaped antibody (or reconstituted antibody)
H%AF,
#UO#kC<2(B
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© zURob MpE#
}/{G
1. ¼òÊö°×ϸ°û½éËØ6(IL-6)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¡£ :mpR}.^hv
qxR7;/@j )
2. ϸ°û¶¾ÐÔTÁܰÍϸ°û(Tc»òCTL)Ó뿹ÌåÒÀÀµµÄϸ°û½éµ¼µÄϸ°û¶¾(ADCC)ɱÉË»úÀíÓкβ»Í¬? { 4(E
@
c,\!<4
3. ¼òÊöµÚ¢ôÐÍ(³Ù·¢ÐÍ)±ä̬·´Ó¦µÄ·¢Éú»úÀí¡£ G31??L:<
z
5T_
4. NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄ±íÃæ±ê¼Ç?NKϸ°ûÓÐÄÄЩÖ÷ÒªµÄÉúÎïѧ»îÐÔ? z
g '1T2t
Ai 9UB=[R
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö) ¹©´«È¾²¡Ñ§×¨ÒµÊÔÌ⣺ =h#3D?b0n
lQnl6j
1. »úÌåÓÐÄÄЩÃâÒßϸ°ûºÍÃâÒß·Ö×Ó²ÎÓ뿹²¡¶¾¸ÐȾ?ËüÃÇÊÇÈçºÎ·¢»Ó²¡¶¾ÃâÒß×÷ÓõÄ? RH=Tu6i
?2#v`Z=L;
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚ²¡¶¾Ñ§ÖÐÓÐÄÄЩÖ÷ÒªÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ ?Cu1"bl
N0D)d
¹©Ïû»¯ÄÚ¿Æ×¨ÒµÊÔÌ⣺ GO=&
41d,<E
1. ĿǰÌåÄÚºÍÌåÍâ¼ì²âÖ×Áö»¼ÕßÃâÒß¹¦Äܵķ½·¨Ö÷ÒªÓÐÄÄЩ?·Ö±ðÐðÊöÿÖÖ·½·¨µÄÔÀíºÍ½á¹û²â¶¨? ]lKQwpX3
jf_0IE
2. Ŀǰµ¥¿Ë¡¿¹ÌåÔÚÖ×ÁöѧÖÐÓÐÄÄЩÖ÷ÒªµÄÓÃ;?½ñºó¿ÉÄÜÓÐÄÄЩÖ÷ÒªµÄ·¢Õ¹·½Ïò? ¡¡ KvFGwq"X
m}x&]">9
µÚËľüÒ½´óѧһ¾Å¾ÅËÄÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ѧ¿Æ×¨Òµ: e@-"B9~
3Mnm2*\
´«È¾²¡Ñ§¡¢ Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿: tPT\uD#t
A1zqm_X5)P
̉񧄤 &*}NN5Sv
Qo4+=^(
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© n.[0#Ur&}
MZ(TST"
1. CD8 FyZa1%Tv@
Wp0e?bK_
2. T cell receptor ¦Á and ¦Â chain (TCR¦Á¦Â ) 6z^Kg~a
%f{1u5+5
3. immunoglobulin fold(Ig fold) 6AZJ,Q\E@
He)<S?X-6
4. cadherin (Ca-dependent cell adhesion moleculers)
G;n'c7BV
y\'t{>U/
5. idiotype-anti-idiotypic antibody immune network theory O1@-)<_71
q;T3bxp+
6. HLA class II antigen TzXivE@mm
wW3fsXu
7. complementarity-determining region (CDR) 8{5Y%InL
uzO%+B!
8. perforin(or pore-forming protein ,PFP) Wgl7)Xk.)
YfC1.8
9. high affinity IL-2 receptor uiO7sf6
yZ[H&>
10. artificial active immunization ta>:iQa
(+<SR5,/3
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£©
f>)k<-<yj
`~Eo;'( +^
1. ¼òÊö°×ϸ°û½éËØ2(IL-2)Ö÷ÒªµÄÉúÎïѧ»îÐÔ¼°ÆäÔÚÁÙ´²ÖÎÁÆÖеÄÓ¦ÓᣠY{X79Rd
k
zhek >
2. Çë±È½ÏµÚ¢ñÐÍ(ËÙ·¢ÐÍ)³¬Ãô·´Ó¦ÓëµÚ¢ôÐÍ(³Ù·¢ÐÍ)³¬Ãô·´Ó¦µÄ·¢²¡Ìص㡣 PaF`dnJ
=,0E]MZ
3. ÊÔÊö·ÖÃÚÐÍIgA(secretory IgA)µÄ½á¹¹ÌصãºÍºÏ³É·ÖÃÚ¹ý³Ì¡£ qp*C%U
y]5O45E0
4. ÊԱȽÏT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(Èç±íÃæ¿¹Ô¡¢±íÃæÊÜÌåµÈ)µÄÒìͬµã¡£ R07Kure
BN&^$1F((
Èý. ÎÊ´ðÌâ(ÿÌâ14·Ö,¹²28·Ö¡£Çë×¢Ò⣺ÿλ¿¼ÉúÖ»ÄÜ´Ó1¡¢2ÌâÖÐѡһÌâ,3¡¢4ÌâÖÐѡһÌâ,¹²´ðÁ½Ìâ,¶à´ðÕß²»¼Æ·Ö¡£) 1. Ŀǰ¼ì²âϸ°ûÒò×ÓÖ÷ÒªÓÐÉúÎïѧ»îÐÔ¼ì²â·¨ºÍÃâÒßѧ¼ì²â·¨,Çë¾ÙÀý·Ö±ðÐðÊöÁ½ÖÖ·½·¨µÄʵÑéÔÀí¡£ ?Kw~O"L8
Vx@JP93|
2. ΪÁ˱ÜÃâIgG¿¹ÌåFc¶Î·ÇÌØÒìÐÔ×÷ÓÃ,³£Ó¦ÓÃθµ°°×øˮ½âµÄF(ab¡¯)2¶Î,ÊÔÎÊÈçºÎÓ¦ÓÃSDS-PAGE·½·¨¶ÔF(ab¡¯)2½øÐмø¶¨? "d'D:>z]%
x^kV;^ I
3. ÊÔÊö¿¹Ö×Áö»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ <syMrXk)R(
A-\OB
Nh
4. ÊÔÊö¿¹²¡¶¾»ùÒò¹¤³Ì¿¹ÌåµÄÑо¿½øÕ¹¡£ ¡¡ &MnS(
82L
YaJ[39V
µÚËľüÒ½´óѧһ¾Å¾ÅÎåÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ oL
Eqy
K_
P08
ѧ¿Æ×¨Òµ£ºÃâÒßѧ¡¢´«È¾²¡Ñ§¡¢Ïû»¯ÄÚ¿Æ ¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ 1BK-uv:
tz-, |n0
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© z{U2K'
LutP&Ebt8
1. immunoglobulin gene rearrangement 0R&$P6
5LU8QHj3
2. the common chain of cytokine receptor (or a cytokine receptor subunit shared by some cytokine receptors) ;^nN!KDjR
g$<Sh.4A
3. flow cytometry(FCM) 5y;texsj[
lAU`7uE
4. carrier effect '+LbFGrO3
8 SII>iL{
5. positive selection of T lymphocytes in thymus Pu dIb|V2
XVcY?_AS#
6. mouse TH1(Th1) and TH2(Th2) subsets {fe[$KQ
-J8&!S8 X
7. perforin (pore-forming protein ,PFP) U:xY~>
e E:
J
8. ADCC(antibody-dependent cell-mediated cytotoxicity) U_
ELeW5@
rM/Ona2x
9. SH-2(src-homology region 2) K
TJm[44
K*^3FO}JG
10. Ab2¦Â (internal image) X6I"&yct
%O]]La
¶þ. ¼ò´ðÌ⣨ÿÌâ8·Ö£¬¹²32·Ö£© (/TYET_H
S-{=4b'
1. ½üÄêÀ´ÔÚÈËÀà°×ϸ°û·Ö»¯¿¹Ô(CD)Ñо¿ÁìÓòÖÐÓÐÄÄЩÖ÷Òª½øÕ¹? *Ii_dpJ
J?VMQTa/+
2. ²ÎÓë»î»¯Tϸ°ûÓë»î»¯Bϸ°ûÏ໥×÷ÓõķÖ×ÓÖ÷ÒªÓÐÄÄЩ?¼òÊöÆä½á¹¹ºÍ¹¦ÄÜ? ASA ]7qyO
0;9X`z
J
3. ÊÔÊöHLAÔÚÁÙ´²ÉϵÄÖ÷ÒªÓ¦Óᣠ_Q)rI%A2
-JgN$Sf
4. Àý¾ÙÈýÖÖ´ÓÈËÍâÖÜѪµ¥¸öºËϸ°û(PBMC)Öд¿»¯Tϸ°ûµÄ·½·¨,·Ö±ðÐðÊöÆäʵÑéÔÀíºÍÖ÷Òª²Ù×÷²½Öè¡£
WUnz
FI|jsO 3
5. ÆÀ¼Ûºìϸ°ûÉú³ÉËØ(EPO)¡¢¸ÉÈÅËØ(IFN)ºÍ¼¯Âä´Ì¼¤Òò×Ó(CSF)ÔÚÁÙ´²Ä³Ð©¼²²¡µÄÓ¦ÓᣠZ!HQ|')N5
*K}h
>b 1
Èý. Ñ¡ÔñÎÊ´ðÌâ(ÿÌâ10·Ö,¹²20·Ö¡£Çë°´±¨¿¼×¨Òµ´ðÌâ,Èç´ð·Ç±¾×¨ÒµÌâ»ò¶à´ðÌâ¾ùÊÓΪÎÞЧ¡£) FfEP@$
{vCB$@/o
ÃâÒßѧרҵ£º hb@,fgo!Q
cg`bbZ
1. ÊÔÊöϸ°ûÒò×ÓÊÜÌåÖÐ,Ig³¬¼Ò×å¡¢ÔìѪÒò×ÓÊÜÌ峬¼Ò×å¡¢Éñ¾Éú³¤Òò×ÓÊÜÌ峬¼Ò×åÒÔ¼°Ç÷»¯Òò×ÓÊÜÌ峬¼Ò×åµÄÖ÷Òª½á¹¹Ìصã,ÿ¸ö³¬¼Ò×åÀý¾Ù³ö2¸ö³ÉÔ±¡£ FFC"rG
))M!"*
2. ÊԱȽÏÈËT¡¢BÁܰÍϸ°ûϸ°ûĤ±íÃæ·Ö×Ó(±íÃæ±ê¼Ç)µÄÒìͬµã,ËüÃÇ·Ö±ð²ÎÓëÄÄЩÖ÷ÒªµÄÃâÒß¹¦ÄÜ? 1nGpW$Gx
K"fr4xHq
´«È¾²¡Ñ§×¨Òµ£º =(]yl_
s>pM+PoGYd
1. ÈËÀàÃâÒßȱÏݲ¡¶¾(HIV)¸ÐȾÈËÌåºó,ÃâÒß¹¦Äܿɷ¢ÉúÄÄЩÖ÷ÒªµÄ±ä»¯?»úÀíÊÇʲô?ÈçºÎ½øÐÐÏàÓ¦µÄÃâÒßѧ¹¦Äܼì²â£¿ e'nhP
qXF#qS-28
2. ÇëÆÀÊöÉö×ÛºÏÕ÷³öѪÈȲ¡¶¾(HFRSV)¸ÐȾºó»úÌåÃâÒßѧ±ä»¯µÄÓ벡ÀíËðÉ˵ĹØÏµ¡£ y6#AL<W@=
c+a" sx\
Ïû»¯×¨Òµ£º k`aHG8
S\
=[_=y=G
1.ÊÔÊöÓëÏû»¯ÏµÍ³ÓйصÄÖ×ÁöÏà¹Ø¿¹ÔÑо¿µÄ½øÕ¹¡£ uv#."_Va
I
0vJJP#
2.¼òÊöճĤÏà¹ØÁܰÍÑù×éÖ¯(mucosal assiociated lymphoid tissue,MALT)µÄ×é³ÉºÍ¹¦ÄÜÌØµã¡£·ÖÃÚÐÍIgAÊÇÈçºÎ½øÐкϳɺͷÖÃÚµÄ? 1iLr
KA
^uCZO
µÚËľüÒ½´óѧһ¾Å¾ÅÁùÄê¹¥¶Á²©Ê¿Ñ§Î»Èëѧ¿¼ÊÔÊÔÌâ ÃâÒßѧÊÔÌâ .:wo
AR
W!
sa?Ul)L2
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© W]B75
nyl[d|pVa
1. Fas(CD95)/FasL
{e]ktj#+{
pB;8yz=
2. common chain of cytokine receptor tS[@3h
"h
\ (a<
3 . TCR/CD3 complex a[
Y\5Ojm
oVAY}q|wU
4. negaive selection of thymocytes
I?R?rW
jt?DogYx
5. artificial active immune \2#j1/d4
"K)ue@?
6. anti-idiotypic Sv>bU4LHf
'UFPQ
7. IgSF hd%O\D?
(k$KUP
8. Integrin Cj5=UUnO
qe_qag9
9. chemokine U$m[{r2M
W6&mXJ^3L
10. B7/CD28 d`sIgll&n
6|10OTVu`
¶þ. ÎÊ´ðÌ⣨ÿÌâ12·Ö£¬¹²60·Ö£© w|[{xn^R
#>_5PdO
1. ±È½ÏMHC¢ñºÍMHC¢òÀ࿹ԲÎÓëµÄ¼Ó¹¤Ìá³Ê¿¹ÔµÄ¹ý³Ì¡£ L)QAI5
o:3
m#|h22^H
2. ±È½ÏCTLºÍNKɱÉ˰Ðϸ°ûʱʶ±ðºÍɱÉË»úÖÆµÄÌØµã¡£ I4Rd2G_
qBF}-N_
3. ±È½ÏÃâÒßѧ¼ì²â·¨ºÍÉúÎïѧ»îÐÔ¼ì²â·¨¼ì²âϸ°ûÒò×ÓµÄÓÅȱµã¡£ c.{t +OR
fqm-?vy}
4. ·¢ÏÖÒ»ÖÖеİ×ϸ°û·Ö»¯¿¹Ô»òÖ×ÁöÏà¹Ø¿¹Ô,²¢ÖƱ¸Á˵¥¿Ë¡¿¹Ìå,ÊÔÉè¼ÆÊµÑé·½°¸¿Ë¡´Ë»ùÒò¡£
&:[hUn8jU
E5Zxp3 N
5. Ñ¡ÔñÏÂÊöÖÐÒ»¸öרÌâ,ÐðÊöÎÒ¹úÔÚÕâÒ»Ñо¿ÁìÓòµÄÏÖ×´¼°ÃæÁÙµÄÌôÕ½1)Ö×ÁöÃâÒߣ»(2)»ùÒòÖÎÁÆ£»(3)CD¿¹Ô¡£ Lgrpy
8T"8C
µÚËľüÒ½´óѧһ¾Å¾ÅÆßÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÃâÒßѧÊÔÌâ Z_(P^/
P.W@5:sD
Ò». Ãû´Ê½âÊÍ£¨Ã¿Ìâ4·Ö£¬¹²40·Ö£© hwi$:[
xY@<